tretazicar has been researched along with nitrofurantoin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Bridgewater, JA; Collins, MK; Knox, RJ; Pitts, JD; Springer, CJ | 1 |
Cenas, N; Dickancaite, E; Miskiniene, V; Nemeikaite, A | 1 |
3 other study(ies) available for tretazicar and nitrofurantoin
Article | Year |
---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
The bystander effect of the nitroreductase/CB1954 enzyme/prodrug system is due to a cell-permeable metabolite.
Topics: 3T3 Cells; Animals; Anti-Infective Agents; Antineoplastic Agents; Aziridines; Blotting, Western; Cell Membrane Permeability; Cell Survival; Culture Media, Conditioned; Gene Transfer Techniques; Genetic Therapy; Metronidazole; Mice; Nitrofurantoin; Nitroreductases; Prodrugs | 1997 |
Nitroaromatic betulin derivatives as redox cycling agents.
Topics: Animals; Aziridines; Dicumarol; Dose-Response Relationship, Drug; Ferredoxin-NADP Reductase; Fibroblasts; Furans; Kidney; L-Lactate Dehydrogenase; L-Lactate Dehydrogenase (Cytochrome); Leukemia Virus, Bovine; NAD(P)H Dehydrogenase (Quinone); Nitro Compounds; Nitrobenzoates; Nitrofurantoin; Oxidation-Reduction; Oxidative Stress; Substrate Specificity; Toxicity Tests; Triterpenes | 1997 |